DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Hersh E, Millward M, Elias I. et al.
Phase 3, randomized, open-label, multicenter trial of nab-paclitaxel (nab-P) vs. dacarbazine (DTIC) in previously untreated patients with metastatic malignant melanoma (MMM).
Pigment Cell Melanoma Res 2016;
25: 836-903
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.